Neogen Corporation Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31)
Neogen Corporation (NEOG) reported Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) of 150.00% for the 1-month period ending 2009-12-15, per its 10-K filed 2012-07-30.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio · last filed 2012-07-30
- 2009-12-15: Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) 1 month 150.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) 1 month |
|---|---|
| 2009-12-15 | 150.00% 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |